Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 38.2633.6826.0334.4025.13

What is the latest EV/EBIT ratio of TORRENT PHARMACEUTICALS ?

The latest EV/EBIT ratio of TORRENT PHARMACEUTICALS is 38.26 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202538.26
Mar202433.68
Mar202326.03
Mar202234.40
Mar202125.13

How is EV/EBIT of TORRENT PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 38.26
13.60
Mar2024 33.68
29.39
Mar2023 26.03
-24.33
Mar2022 34.4
36.89
Mar2021 25.13 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/EBIT ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹137,282.1 Cr 2.1% 2.8% 30.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics
MANKIND PHARMA ₹86,144.2 Cr 0.2% -6.3% -16.6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.1%

2.8%

30.9%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses